ºÝºÝߣshows by User: wellsgj / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: wellsgj / Wed, 11 Feb 2015 10:29:06 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: wellsgj Is It Safe? �A Cautionary Tale and Practical Guide to Laboratory Safety and Compliance with the OSHA Lab Standard Regulations /slideshow/is-it-safe-lab-safety-and-osha-lab-std-webinar/44554424 isitsafelabsafetyandoshalabstdwebinar-150211102906-conversion-gate01
Review of several recent tragic lab accidents, some common elements that lead to them, and guidelines and controls for accident prevention. Summary of the OSHA Lab Standard Regulations (29 CFR 1910.1450).]]>
Review of several recent tragic lab accidents, some common elements that lead to them, and guidelines and controls for accident prevention. Summary of the OSHA Lab Standard Regulations (29 CFR 1910.1450).]]> Wed, 11 Feb 2015 10:29:06 GMT /slideshow/is-it-safe-lab-safety-and-osha-lab-std-webinar/44554424 wellsgj@slideshare.net(wellsgj) Is It Safe? �A Cautionary Tale and Practical Guide to Laboratory Safety and Compliance with the OSHA Lab Standard Regulations wellsgj Review of several recent tragic lab accidents, some common elements that lead to them, and guidelines and controls for accident prevention. Summary of the OSHA Lab Standard Regulations (29 CFR 1910.1450). <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/isitsafelabsafetyandoshalabstdwebinar-150211102906-conversion-gate01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Review of several recent tragic lab accidents, some common elements that lead to them, and guidelines and controls for accident prevention. Summary of the OSHA Lab Standard Regulations (29 CFR 1910.1450).
Is It Safe? A Cautionary Tale and Practical Guide to Laboratory Safety and Compliance with the OSHA Lab Standard Regulations from Gregory J. Wells
]]> 1771 4 https://cdn.slidesharecdn.com/ss_thumbnails/isitsafelabsafetyandoshalabstdwebinar-150211102906-conversion-gate01-thumbnail.jpg?width=120&height=120&fit=bounds presentation 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Pyrrolotriazines as Novel Potent ALK Inhibitors /wellsgj/pyrolotriazin-alk-gjw pyrolotriazinalkgjw-13518921027794-phpapp01-121102164350-phpapp01
Discovery and development of 2,7-Disubstituted-Pyrrolo[2,1-f][1,2,4]triazines. A New Class of Anaplastic Lymphoma Kinase(ALK)*Inhibitors with in-vivo Anti-tumor Efficacy]]>
Discovery and development of 2,7-Disubstituted-Pyrrolo[2,1-f][1,2,4]triazines. A New Class of Anaplastic Lymphoma Kinase(ALK)*Inhibitors with in-vivo Anti-tumor Efficacy]]> Fri, 02 Nov 2012 16:43:36 GMT /wellsgj/pyrolotriazin-alk-gjw wellsgj@slideshare.net(wellsgj) Pyrrolotriazines as Novel Potent ALK Inhibitors wellsgj Discovery and development of 2,7-Disubstituted-Pyrrolo[2,1-f][1,2,4]triazines. A New Class of Anaplastic Lymphoma Kinase(ALK)*Inhibitors with in-vivo Anti-tumor Efficacy <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pyrolotriazinalkgjw-13518921027794-phpapp01-121102164350-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Discovery and development of 2,7-Disubstituted-Pyrrolo[2,1-f][1,2,4]triazines. A New Class of Anaplastic Lymphoma Kinase(ALK)*Inhibitors with in-vivo Anti-tumor Efficacy
Pyrrolotriazines as Novel Potent ALK Inhibitors from Gregory J. Wells
]]> 1430 2 https://cdn.slidesharecdn.com/ss_thumbnails/pyrolotriazinalkgjw-13518921027794-phpapp01-121102164350-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Benzothiazines As Novel Peptide Mimetic Calpain Inhibitors /slideshow/benzothiazines-as-novel-peptide-mimetic-calpain-inhibitors-8446645/8446645 calpainpresentation-13092673740781-phpapp02-110628082500-phpapp02
Discovery and development of a novel peptidomimetic for potential treatment of ischemic stroke or traumatic spinal cord injury.]]>
Discovery and development of a novel peptidomimetic for potential treatment of ischemic stroke or traumatic spinal cord injury.]]> Tue, 28 Jun 2011 08:24:38 GMT /slideshow/benzothiazines-as-novel-peptide-mimetic-calpain-inhibitors-8446645/8446645 wellsgj@slideshare.net(wellsgj) Benzothiazines As Novel Peptide Mimetic Calpain Inhibitors wellsgj Discovery and development of a novel peptidomimetic for potential treatment of ischemic stroke or traumatic spinal cord injury. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/calpainpresentation-13092673740781-phpapp02-110628082500-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Discovery and development of a novel peptidomimetic for potential treatment of ischemic stroke or traumatic spinal cord injury.
Benzothiazines As Novel Peptide Mimetic Calpain Inhibitors from Gregory J. Wells
]]> 2069 2 https://cdn.slidesharecdn.com/ss_thumbnails/calpainpresentation-13092673740781-phpapp02-110628082500-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 PARP-1 Inhibitors In Oncology /slideshow/parp1-inhibitors-in-oncology/8280850 parp1inhibitorsinoncology-1307813785662-phpapp02-110611124141-phpapp02
Discovery and development of CEP-9722, currently Phase 2 for adjuvant cancer therapy.]]>
Discovery and development of CEP-9722, currently Phase 2 for adjuvant cancer therapy.]]> Sat, 11 Jun 2011 12:40:32 GMT /slideshow/parp1-inhibitors-in-oncology/8280850 wellsgj@slideshare.net(wellsgj) PARP-1 Inhibitors In Oncology wellsgj Discovery and development of CEP-9722, currently Phase 2 for adjuvant cancer therapy. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/parp1inhibitorsinoncology-1307813785662-phpapp02-110611124141-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Discovery and development of CEP-9722, currently Phase 2 for adjuvant cancer therapy.
PARP-1 Inhibitors In Oncology from Gregory J. Wells
]]> 6009 6 https://cdn.slidesharecdn.com/ss_thumbnails/parp1inhibitorsinoncology-1307813785662-phpapp02-110611124141-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-wellsgj-48x48.jpg?cb=1523080174 - Medicinal and Synthetic Chemist specializing in structure-based drug design and biophysical optimization, particularly in the areas of cardiovascular, oncology, and CNS drugs. - Laboratory expertise in the synthesis, purification, and analysis of heterocycles, peptides, peptidomimetics, organofluorides, organosilanes, organometallics, pro-drugs, chiral compounds, and inorganics. - All phases of Pharmaceutical R&D from Discovery through Process R&D, including cGMP of pre-clinical candidates up to pilot plant scale. - Lab Safety and Chemical Hygiene; OSHA and EPA compliance; chemical inventory management. - Group Leader and Lab Supervisor of Technician through Ph.D. level personnel.... http://www.chemconsultants.org/resumes/wells_gj.html https://cdn.slidesharecdn.com/ss_thumbnails/isitsafelabsafetyandoshalabstdwebinar-150211102906-conversion-gate01-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/is-it-safe-lab-safety-and-osha-lab-std-webinar/44554424 Is It Safe? �A Caution... https://cdn.slidesharecdn.com/ss_thumbnails/pyrolotriazinalkgjw-13518921027794-phpapp01-121102164350-phpapp01-thumbnail.jpg?width=320&height=320&fit=bounds wellsgj/pyrolotriazin-alk-gjw Pyrrolotriazines as No... https://cdn.slidesharecdn.com/ss_thumbnails/calpainpresentation-13092673740781-phpapp02-110628082500-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/benzothiazines-as-novel-peptide-mimetic-calpain-inhibitors-8446645/8446645 Benzothiazines As Nove...